These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis. Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795 [TBL] [Abstract][Full Text] [Related]
5. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases. Na R; Ye D; Qi J; Liu F; Lin X; Helfand BT; Brendler CB; Conran C; Gong J; Wu Y; Gao X; Chen Y; Zheng SL; Mo Z; Ding Q; Sun Y; Xu J Asian J Androl; 2016; 18(4):525-9. PubMed ID: 27140652 [TBL] [Abstract][Full Text] [Related]
6. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. Woods-Burnham L; Basu A; Cajigas-Du Ross CK; Love A; Yates C; De Leon M; Roy S; Casiano CA Prostate; 2017 Dec; 77(16):1601-1608. PubMed ID: 29030865 [TBL] [Abstract][Full Text] [Related]
7. Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB. Wei J; Shi Z; Na R; Resurreccion WK; Wang CH; Duggan D; Zheng SL; Hulick PJ; Helfand BT; Xu J J Med Genet; 2022 Mar; 59(3):243-247. PubMed ID: 33443076 [TBL] [Abstract][Full Text] [Related]
8. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial. Chen H; Liu X; Brendler CB; Ankerst DP; Leach RJ; Goodman PJ; Lucia MS; Tangen CM; Wang L; Hsu FC; Sun J; Kader AK; Isaacs WB; Helfand BT; Zheng SL; Thompson IM; Platz EA; Xu J Prostate; 2016 Sep; 76(12):1120-9. PubMed ID: 27197965 [TBL] [Abstract][Full Text] [Related]
9. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values. Yu H; Shi Z; Wu Y; Wang CH; Lin X; Perschon C; Isaacs WB; Helfand BT; Lilly Zheng S; Duggan D; Mo Z; Lu D; Xu J Prostate; 2019 Jul; 79(10):1099-1105. PubMed ID: 31037745 [TBL] [Abstract][Full Text] [Related]
10. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis. Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031 [TBL] [Abstract][Full Text] [Related]
11. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. Seibert TM; Garraway IP; Plym A; Mahal BA; Giri V; Jacobs MF; Cheng HH; Loeb S; Helfand BT; Eeles RA; Morgan TM Eur Urol; 2023 Mar; 83(3):241-248. PubMed ID: 36609003 [TBL] [Abstract][Full Text] [Related]
12. Genetic structure and differentiation analysis of a Eurasian Uyghur population by use of 27 continental ancestry-informative SNPs. Wei YL; Sun QF; Li Q; Yi JL; Zhao L; Ou Y; Jiang L; Zhang T; Liu HB; Chen JG; Zhu BF; Ye J; Hu L; Li CX Int J Legal Med; 2016 Jul; 130(4):897-903. PubMed ID: 26932865 [TBL] [Abstract][Full Text] [Related]
13. Variability of 128 schizophrenia-associated gene variants across distinct ethnic populations. Ohi K; Shimada T; Yasuyama T; Uehara T; Kawasaki Y Transl Psychiatry; 2017 Jan; 7(1):e988. PubMed ID: 28045464 [TBL] [Abstract][Full Text] [Related]
14. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer. Conran CA; Na R; Chen H; Jiang D; Lin X; Zheng SL; Brendler CB; Xu J Asian J Androl; 2016; 18(4):520-4. PubMed ID: 27080480 [TBL] [Abstract][Full Text] [Related]
15. Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score. Helfand BT; Chen H; Fantus RJ; Conran CA; Brendler CB; Zheng SL; Walsh PC; Isaacs WB; Xu J Prostate; 2018 Jun; ():. PubMed ID: 29923209 [TBL] [Abstract][Full Text] [Related]
16. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Conti DV; Darst BF; Moss LC; Saunders EJ; Sheng X; Chou A; Schumacher FR; Olama AAA; Benlloch S; Dadaev T; Brook MN; Sahimi A; Hoffmann TJ; Takahashi A; Matsuda K; Momozawa Y; Fujita M; Muir K; Lophatananon A; Wan P; Le Marchand L; Wilkens LR; Stevens VL; Gapstur SM; Carter BD; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Giles GG; Southey MC; MacInnis RJ; Cybulski C; Wokołorczyk D; Lubiński J; Neal DE; Donovan JL; Hamdy FC; Martin RM; Nordestgaard BG; Nielsen SF; Weischer M; Bojesen SE; Røder MA; Iversen P; Batra J; Chambers S; Moya L; Horvath L; Clements JA; Tilley W; Risbridger GP; Gronberg H; Aly M; Szulkin R; Eklund M; Nordström T; Pashayan N; Dunning AM; Ghoussaini M; Travis RC; Key TJ; Riboli E; Park JY; Sellers TA; Lin HY; Albanes D; Weinstein SJ; Mucci LA; Giovannucci E; Lindstrom S; Kraft P; Hunter DJ; Penney KL; Turman C; Tangen CM; Goodman PJ; Thompson IM; Hamilton RJ; Fleshner NE; Finelli A; Parent MÉ; Stanford JL; Ostrander EA; Geybels MS; Koutros S; Freeman LEB; Stampfer M; Wolk A; Håkansson N; Andriole GL; Hoover RN; Machiela MJ; Sørensen KD; Borre M; Blot WJ; Zheng W; Yeboah ED; Mensah JE; Lu YJ; Zhang HW; Feng N; Mao X; Wu Y; Zhao SC; Sun Z; Thibodeau SN; McDonnell SK; Schaid DJ; West CML; Burnet N; Barnett G; Maier C; Schnoeller T; Luedeke M; Kibel AS; Drake BF; Cussenot O; Cancel-Tassin G; Menegaux F; Truong T; Koudou YA; John EM; Grindedal EM; Maehle L; Khaw KT; Ingles SA; Stern MC; Vega A; Gómez-Caamaño A; Fachal L; Rosenstein BS; Kerns SL; Ostrer H; Teixeira MR; Paulo P; Brandão A; Watya S; Lubwama A; Bensen JT; Fontham ETH; Mohler J; Taylor JA; Kogevinas M; Llorca J; Castaño-Vinyals G; Cannon-Albright L; Teerlink CC; Huff CD; Strom SS; Multigner L; Blanchet P; Brureau L; Kaneva R; Slavov C; Mitev V; Leach RJ; Weaver B; Brenner H; Cuk K; Holleczek B; Saum KU; Klein EA; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Kim J; Neuhausen SL; Steele L; Ding YC; Isaacs WB; Nemesure B; Hennis AJM; Carpten J; Pandha H; Michael A; De Ruyck K; De Meerleer G; Ost P; Xu J; Razack A; Lim J; Teo SH; Newcomb LF; Lin DW; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Lessel D; Kulis T; Usmani N; Singhal S; Parliament M; Claessens F; Joniau S; Van den Broeck T; Gago-Dominguez M; Castelao JE; Martinez ME; Larkin S; Townsend PA; Aukim-Hastie C; Bush WS; Aldrich MC; Crawford DC; Srivastava S; Cullen JC; Petrovics G; Casey G; Roobol MJ; Jenster G; van Schaik RHN; Hu JJ; Sanderson M; Varma R; McKean-Cowdin R; Torres M; Mancuso N; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Nakagawa H; Witte JS; Eeles RA; Kote-Jarai Z; Haiman CA Nat Genet; 2021 Jan; 53(1):65-75. PubMed ID: 33398198 [TBL] [Abstract][Full Text] [Related]
18. A Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization. Smith JL; Tcheandjieu C; Dikilitas O; Lyer K; Miyazawa K; Hilliard A; Lynch J; Rotter JI; Chen YI; Sheu WH; Chang KM; Kanoni S; Tsao P; Ito K; Kosel M; Clarke SL; Schaid DJ; Assimes TL; Kullo IJ medRxiv; 2023 Jun; ():. PubMed ID: 37609230 [TBL] [Abstract][Full Text] [Related]
19. Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients. Xu J; Isaacs WB; Mamawala M; Shi Z; Landis P; Petkewicz J; Wei J; Wang CH; Resurreccion WK; Na R; Bhanji Y; Novakovic K; Walsh PC; Zheng SL; Helfand BT; Pavlovich CP Prostate; 2021 Jul; 81(10):703-709. PubMed ID: 33956350 [TBL] [Abstract][Full Text] [Related]
20. A genetic risk score comprising known venous thromboembolism loci is associated with chronic venous disease in a multi-ethnic cohort. Wassel CL; Rasmussen-Torvik LJ; Callas PW; Denenberg JO; Durda JP; Reiner AP; Smith NL; Allison MA; Rosendaal FR; Criqui MH; Cushman M Thromb Res; 2015 Nov; 136(5):966-73. PubMed ID: 26442836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]